Polymorphisms in the 5′- and 3′-untranslated region of the VEGF gene and sporadic breast cancer risk and clinicopathologic characteristics

Vascular endothelial growth factor and its relationship to the prognosis and treatment of breast, ovarian, and cervical cancer

(2010) Jennifer Delli Carpini et al.   ANGIOGENESIS

Vascular Endothelial Growth Factor in the Serum of Breast Cancer Patients

(2010) T. T. Berezov et al.   BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE

VEGFA + 936C>T polymorphism and cancer risk: a meta-analysis

(2010) Bin Xu et al.   CANCER GENETICS AND CYTOGENETICS

Interethnic Differences in the Distribution of Clinically Relevant Vascular Endothelial Growth Factor Genetic Polymorphisms

(2009) Jaqueline J. Muniz et al.   DNA AND CELL BIOLOGY

Combinational Polymorphisms of Seven CXCL12-Related Genes Are Protective against Breast Cancer in Taiwan

(2009) Gau-Tyan Lin et al.   OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY

A distinct microvascular pattern accompanied by aggressive clinical course in breast carcinomas: A fact or a coincidence?

(2009) Mükerrem Safali et al.   PATHOLOGY RESEARCH AND PRACTICE

Prognostic Significance of Intratumoral and Peritumoral Lymphatic Density and Blood Vessel Density in Invasive Breast Carcinomas

(2008) Yasser M. El-Gohary et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications

(2008) Rabab A. A. Mohammed et al.   BREAST CANCER RESEARCH AND TREATMENT

The VEGF_936_C>T 3′UTR polymorphism reduces BRCA1-associated breast cancer risk in Polish women

(2008) Anna Jakubowska et al.   CANCER LETTERS

Evaluation of serum vascular endothelial growth factor (VEGF) and microvessel density (MVD) as prognostic indicators in carcinoma breast

(2008) S. Shivakumar et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY